Schrezenmeier H - Search Results

1

Differentially induced immunity in buccal and nasal mucosae after vaccination for SARS-CoV-2: Prospects for mass scale immunity-screening in large populations.

Tsamadou C, Ludwig C, Scholz J, Proffen M, Hägele J, Rode I, Körper S, Fabricius D, Jahrsdörfer B, Neuchel C, Amann E, Schrezenmeier H, Fürst D. Tsamadou C, et al. Among authors: schrezenmeier h. Front Immunol. 2022 Nov 17;13:999693. doi: 10.3389/fimmu.2022.999693. eCollection 2022. Front Immunol. 2022. PMID: 36466833 Free PMC article.

2

The K+ channel openers diazoxide and NS1619 induce depolarization of mitochondria and have differential effects on cell Ca2+ in CD34+ cell line KG-1a.

Körper S, Nolte F, Rojewski MT, Thiel E, Schrezenmeier H. Körper S, et al. Among authors: schrezenmeier h. Exp Hematol. 2003 Sep;31(9):815-23. doi: 10.1016/s0301-472x(03)00199-1. Exp Hematol. 2003. PMID: 12962728 Free article.

3

The role of mitochondrial targeting in arsenic trioxide-induced apoptosis in myeloid cell lines.

Körper S, Nolte F, Thiel E, Schrezenmeier H, Rojewski MT. Körper S, et al. Among authors: schrezenmeier h. Br J Haematol. 2004 Jan;124(2):186-9. doi: 10.1046/j.1365-2141.2003.04742.x. Br J Haematol. 2004. PMID: 14687028 Free article.

4

Arsenic trioxide-induced apoptosis is independent of CD95 in lymphatic cell lines.

Rojewski MT, Körper S, Thiel E, Schrezenmeier H. Rojewski MT, et al. Among authors: schrezenmeier h. Oncol Rep. 2004 Feb;11(2):509-13. Oncol Rep. 2004. PMID: 14719092

5

Depolarization of mitochondria and activation of caspases are common features of arsenic(III)-induced apoptosis in myelogenic and lymphatic cell lines.

Rojewski MT, Körper S, Thiel E, Schrezenmeier H. Rojewski MT, et al. Among authors: schrezenmeier h. Chem Res Toxicol. 2004 Jan;17(1):119-28. doi: 10.1021/tx034104+. Chem Res Toxicol. 2004. PMID: 14727926

6

Depolarisation of the plasma membrane in the arsenic trioxide (As2O3)-and anti-CD95-induced apoptosis in myeloid cells.

Nolte F, Friedrich O, Rojewski M, Fink RH, Schrezenmeier H, Körper S. Nolte F, et al. Among authors: schrezenmeier h. FEBS Lett. 2004 Dec 3;578(1-2):85-9. doi: 10.1016/j.febslet.2004.10.075. FEBS Lett. 2004. PMID: 15581621 Free article.

7

Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside.

Rojewski MT, Körper S, Schrezenmeier H. Rojewski MT, et al. Among authors: schrezenmeier h. Leuk Lymphoma. 2004 Dec;45(12):2387-401. doi: 10.1080/10428190412331272686. Leuk Lymphoma. 2004. PMID: 15621751 Review.

8

The frequency of DRB1*1454 in South German Caucasians.

Fürst D, Solgi G, Schrezenmeier H, Mytilineos J. Fürst D, et al. Among authors: schrezenmeier h. Tissue Antigens. 2010 Jul;76(1):57-9. doi: 10.1111/j.1399-0039.2010.01461.x. Epub 2010 Mar 4. Tissue Antigens. 2010. PMID: 20210922

9

Sequence-based typing of major histocompatibility complex class I chain-related gene A alleles by use of exons 2-5 information.

Fürst D, Solgi G, Recker K, Mytilineos D, Schrezenmeier H, Mytilineos J. Fürst D, et al. Among authors: schrezenmeier h. Tissue Antigens. 2011 Mar;77(3):201-5. doi: 10.1111/j.1399-0039.2010.01601.x. Tissue Antigens. 2011. PMID: 21299524

10

Human B cells differentiate into granzyme B-secreting cytotoxic B lymphocytes upon incomplete T-cell help.

Hagn M, Sontheimer K, Dahlke K, Brueggemann S, Kaltenmeier C, Beyer T, Hofmann S, Lunov O, Barth TF, Fabricius D, Tron K, Nienhaus GU, Simmet T, Schrezenmeier H, Jahrsdörfer B. Hagn M, et al. Among authors: schrezenmeier h. Immunol Cell Biol. 2012 Apr;90(4):457-67. doi: 10.1038/icb.2011.64. Epub 2011 Aug 2. Immunol Cell Biol. 2012. PMID: 21808264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

348 results

Search Page